Zealand Pharma A/S (CPH:ZEAL)
234.90
-134.30 (-36.38%)
At close: Mar 6, 2026
Zealand Pharma Employees
As of December 31, 2025, Zealand Pharma had 501 total employees, including 481 full-time and 20 part-time employees. The number of employees increased by 146 or 41.13% compared to the previous year.
Employees
501
Change (1Y)
146
Growth (1Y)
41.13%
Revenue / Employee
18.77M DKK
Profits / Employee
13.15M DKK
Market Cap
16.59B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Novo Nordisk | 69,505 |
| Genmab | 2,973 |
| Coloplast | 16,983 |
| ALK-Abelló | 2,613 |
| Demant | 26,704 |
| H. Lundbeck | 5,039 |
| Ambu A/S | 5,200 |
| Bavarian Nordic | 1,738 |
Zealand Pharma News
- 21 hours ago - Disappointing weight-loss-trial results from Zealand Pharma sends shares tumbling - Market Watch
- 1 day ago - Roche's Obesity Drug Shows Promise But Trails GLP-1 Giants Novo Nordisk, Eli Lilly - Benzinga
- 1 day ago - Zealand Pharma slump wipes billions off its value after obesity drug data disappoints - Reuters
- 1 day ago - Roche, Zealand Pharma Obesity Drug Hits Goal in Midstage Trial - WSJ
- 1 day ago - Zealand Pharma announces positive Phase 2 results for petrelintide, an amylin analog with potential to redefine the weight management experience for people living with overweight and obesity - GlobeNewsWire
- 15 days ago - Q4 2025 Zealand Pharma A/S Earnings Call Transcript - GuruFocus
- 15 days ago - Zealand Pharma convenes its Annual General Meeting 2026 - GlobeNewsWire
- 16 days ago - Zealand Pharma Announces Financial Results for the Full Year 2025 - GlobeNewsWire